鞘内吗啡与阻塞性睡眠呼吸暂停关节置换患者术后肺部并发症:回顾性队列研究
这项回顾性队列研究纳入1326例确诊或疑似阻塞性睡眠呼吸暂停的髋/膝关节置换患者,比较接受低剂量(100 μg)鞘内吗啡(1042例)与未用阿片类药物(283例)的术后肺部并发症。结果显示两组肺部并发症发生率无显著差异(1.3% vs 2.1%,P=0.345),校正混杂后鞘内吗啡与肺部并发症无显著关联(aOR 0.60,95%CI 0.24-1.67,P=0.308)。
要点
- 低剂量鞘内吗啡(100 μg)未显著增加阻塞性睡眠呼吸暂停关节置换患者的术后肺部并发症。
- 总体肺部并发症发生率低(1.5%),组间比较无统计学差异。
- 需谨慎解读回顾性设计及对照组样本量较小(283例)的局限性。
核心结论
- 低剂量鞘内吗啡联合多模式镇痛与阻塞性睡眠呼吸暂停关节置换患者术后肺部并发症无可靠关联。
研究设计与样本
- 回顾性队列研究,纳入1326例确诊或疑似阻塞性睡眠呼吸暂停的髋/膝关节置换患者。
- 暴露组接受低剂量(100 μg)鞘内吗啡(1042例,78.6%),对照组未用阿片类药物(283例)。
主要发现
- 术后肺部并发症总发生率1.5%(20/1322),暴露组1.3%(14/1039) vs 对照组2.1%(6/283),P=0.345。
- 呼吸抑制发生率0.5%(6/1322),需重症团队会诊的呼吸事件1.4%(18/1322),非计划ICU入住0.3%(4/1322),两组相似。
- 校正混杂后,鞘内吗啡与术后肺部并发症无显著关联(aOR 0.60,95%CI 0.24-1.67,P=0.308)。
临床怎么用
- 对于阻塞性睡眠呼吸暂停患者行关节置换术,低剂量鞘内吗啡(100 μg)联合多模式镇痛可能不增加术后肺部并发症风险。
局限性
- 回顾性队列设计可能存在残余混杂。
- 对照组样本量较小(283例),事件数少,统计效能有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Intrathecal morphine is commonly and effectively used for analgesia after joint arthroplasty, but has been associated with delayed respiratory depression. Patients with obstructive sleep apnea may be at higher risk of postoperative pulmonary complications. However, data is limited regarding the safety of intrathecal morphine in this population undergoing arthroplasty. METHODS: This retrospective cohort study aimed to determine the safety of intrathecal morphine in 1,326 patients with documented or suspected obstructive sleep apnea undergoing hip or knee arthroplasty. Chart review was performed to determine clinical characteristics, perioperative events, and postoperative outcomes. All patients received neuraxial anesthesia with low-dose (100 μg) intrathecal morphine (exposure) or without opioids (control). The primary outcome was any postoperative pulmonary complication including: (1) respiratory depression requiring naloxone; (2) pneumonia; (3) acute respiratory event requiring consultation with the critical care response team; (4) respiratory failure requiring intubation/mechanical ventilation; (5) unplanned admission to the intensive care unit for respiratory support; and (6) death from a respiratory cause. The authors hypothesized that intrathecal morphine would be associated with increased postoperative complications. RESULTS: In 1,326 patients, 1,042 (78.6%) received intrathecal morphine. The mean age of patients was 65 ± 9 yr and body mass index was 34.7 ± 7.0 kg/m. Of 1,326 patients, 622 (46.9%) had suspected obstructive sleep apnea (Snoring, Tired, Observed, Pressure, Body Mass Index, Age, Neck size, Gender [STOP-Bang] score greater than 3), while 704 of 1,326 (53.1%) had documented polysomnographic diagnosis. Postoperatively, 20 of 1,322 (1.5%) patients experienced pulmonary complications, including 14 of 1,039 (1.3%) in the exposed and 6 of 283 (2.1%) in the control group (P = 0.345). Overall, there were 6 of 1 322 (0.5%) cases of respiratory depression, 18 of 1,322 (1.4%) respiratory events requiring critical care team consultation, and 4 of 1,322 (0.3%) unplanned intensive care unit admissions; these rates were similar between both groups. After adjustment for confounding, intrathecal morphine was not significantly associated with postoperative pulmonary complication (adjusted odds ratio, 0.60 [95% CI, 0.24 to 1.67]; P = 0.308). CONCLUSIONS: Low-dose intrathecal morphine, in conjunction with multimodal analgesia, was not reliably associated with postoperative pulmonary complications in patients with obstructive sleep apnea undergoing joint arthroplasty.
引用
- Bai JW, Singh M, Short A, et al. Intrathecal Morphine and Pulmonary Complications after Arthroplasty in Patients with Obstructive Sleep Apnea: A Retrospective Cohort Study. Anesthesiology. 2020. PMID: 31977522. doi:10.1097/ALN.0000000000003110
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。